Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society.

OBJECTIVE To formulate clinical consensus recommendations on the presentation, assessment, and management of primary hyperparathyroidism (PHPT) in adults. METHODS Representatives from relevant Australian and New Zealand Societies used a systematic approach for adaptation of guidelines (ADAPTE) to derive an evidence-informed position statement addressing nine key questions. RESULTS PHPT is a biochemical diagnosis. Serum calcium should be measured in patients with suggestive symptoms, reduced bone mineral density or minimal trauma fractures, and in those with renal stones. Other indications are detailed in the manuscript. In patients with hypercalcaemia, intact parathyroid hormone, 25-hydroxy vitamin D, phosphate, and renal function should be measured. In established PHPT, assessment of bone mineral density, vertebral fractures, urinary tract calculi/nephrocalcinosis and quantification of urinary calcium excretion is warranted. Parathyroidectomy is the only definitive treatment and is warranted for all symptomatic patients and should be considered for asymptomatic patients without contraindications to surgery and with >10 years life expectancy. In patients who do not undergo surgery, we recommend annual evaluation for disease progression. Where the diagnosis is not clear or the risk-benefit ratio is not obvious, multidisciplinary discussion and formulation of a consensus management plan is appropriate. Genetic testing for familial hyperparathyroidism is recommended in selected patients. CONCLUSIONS These clinical consensus recommendations were developed to provide clinicians with contemporary guidance on the assessment and management of PHPT in adults. It is anticipated that improved health outcomes for individuals and the population will be achieved at a decreased cost to the community.

[1]  L. Rejnmark,et al.  Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis , 2021, Osteoporosis International.

[2]  R. Eastell,et al.  Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best? , 2020, Postgraduate Medical Journal.

[3]  Snehal G. Patel,et al.  Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study. , 2020, Surgery.

[4]  M. Kurajoh,et al.  Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism , 2020, Endocrine.

[5]  A. Gill,et al.  Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing , 2020, Endocrine Pathology.

[6]  S. Wilcox,et al.  Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort , 2020, Clinical endocrinology.

[7]  P. Vestergaard,et al.  Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial. , 2020, The lancet. Diabetes & endocrinology.

[8]  A. Tabarin,et al.  Clinical Characteristics of Familial Hypocalciuric Hypercalcaemia Type 1: A Multicentre Study of 77 Adult Patients. , 2020, Clinical Endocrinology.

[9]  A. Mäkitie,et al.  Parathyroid cancer: An update. , 2020, Cancer treatment reviews.

[10]  R. Eastell,et al.  Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History , 2020, The Journal of clinical endocrinology and metabolism.

[11]  S. Kos,et al.  Clinical guidelines and PTH measurement: does assay generation matter? , 2019, Endocrine reviews.

[12]  S. Silverberg,et al.  Risk factors for vertebral fracture in primary hyperparathyroidism , 2019, Endocrine.

[13]  Yu Xia,et al.  Ultrasound combined with biochemical parameters can predict parathyroid carcinoma in patients with primary hyperparathyroidism , 2019, Endocrine.

[14]  J. Chabot,et al.  Bone mineral density changes after parathyroidectomy are dependent on biochemical profile , 2019, Surgery.

[15]  B. Clarke,et al.  Asymptomatic Primary Hyperparathyroidism. , 2018, Frontiers of hormone research.

[16]  L. Rejnmark,et al.  Health‐related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study , 2018, Clinical endocrinology.

[17]  A. Chou,et al.  Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features , 2018, The American journal of surgical pathology.

[18]  J. Amado,et al.  Bone mineral density evolution and incidence of fractures in a cohort of patients with primary hyperparathyroidism treated with parathyroid surgery vs active surveillance during 6 years of follow-up. , 2019, Endocrinologia, diabetes y nutricion.

[19]  H. Schneider,et al.  Misclassification of Calcium Status Based on Albumin-Adjusted Calcium: Studies in a Tertiary Hospital Setting. , 2018, Clinical chemistry.

[20]  F. Ahmed,et al.  The role of ultrasonography in detecting urinary tract calculi compared to CT scan , 2018, Research and reports in urology.

[21]  D. Shoback,et al.  Familial hypocalciuric hypercalcemia and related disorders. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[22]  J. Bilezikian Primary Hyperparathyroidism , 2018, The Journal of clinical endocrinology and metabolism.

[23]  R. Sippel,et al.  Should Symptoms Be Considered an Indication for Parathyroidectomy in Primary Hyperparathyroidism? , 2018, Clinical medicine insights. Endocrinology and diabetes.

[24]  W. Simonds,et al.  Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. , 2018, Journal of the American College of Surgeons.

[25]  S. Silverberg,et al.  Primary hyperparathyroidism , 2018, Nature Reviews Endocrinology.

[26]  M. Landén,et al.  Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management , 2017, World Journal of Surgery.

[27]  C. Marcocci,et al.  Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features , 2017, PloS one.

[28]  G. Melnichenko,et al.  Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome , 2017, Endocrine connections.

[29]  Maryam K. Mohammed,et al.  Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism , 2017, Surgery.

[30]  James X. Wu,et al.  Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost‐effectiveness analysis incorporating fracture risk reduction , 2017, Surgery.

[31]  M. Tublin,et al.  The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. , 2016, JAMA surgery.

[32]  R. Rizzoli,et al.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus , 2016, Osteoporosis International.

[33]  R. Thakker Genetics of parathyroid tumours , 2016, Journal of internal medicine.

[34]  L. Gianotti,et al.  Forearm DXA Increases the Rate of Patients With Asymptomatic Primary Hyperparathyroidism Meeting Surgical Criteria. , 2016, The Journal of clinical endocrinology and metabolism.

[35]  Ning Li,et al.  The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism , 2016, Annals of Internal Medicine.

[36]  C. Marcocci,et al.  Primary hyperparathyroidism , 2016, Nature Reviews Disease Primers.

[37]  M. Pawłowska,et al.  An overview of normocalcemic primary hyperparathyroidism , 2015, Current opinion in endocrinology, diabetes, and obesity.

[38]  M. Prasad,et al.  Modern experience with aggressive parathyroid tumors in a high-volume New England referral center. , 2015, Journal of the American College of Surgeons.

[39]  K. Kos,et al.  Parathyroid Hormone, Cognitive Function and Dementia: A Systematic Review , 2015, PloS one.

[40]  Y. Toledano,et al.  Pregnancy outcomes in women with primary hyperparathyroidism. , 2015, The Journal of clinical endocrinology and metabolism.

[41]  J. Bilezikian,et al.  Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. , 2015, The Journal of clinical endocrinology and metabolism.

[42]  J. Nordenström,et al.  Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. , 2015, The Journal of clinical endocrinology and metabolism.

[43]  W. Simonds,et al.  Hyperparathyroidism-jaw tumor syndrome: Results of operative management. , 2014, Surgery.

[44]  A. Jiménez-García,et al.  Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study. , 2014, Surgery.

[45]  C. Marcocci,et al.  Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. , 2014, The Journal of clinical endocrinology and metabolism.

[46]  L. Rejnmark,et al.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.

[47]  Q. Duh,et al.  The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.

[48]  E. Hagström,et al.  Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts. , 2014, The Journal of clinical endocrinology and metabolism.

[49]  J. Bilezikian,et al.  Bone disease in primary hyperparathyroidism. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[50]  Collin J. Weber,et al.  Predictors of Bone Mineral Density Improvement in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism , 2014, World Journal of Surgery.

[51]  A. Gill Understanding the Genetic Basis of Parathyroid Carcinoma , 2014, Endocrine Pathology.

[52]  R. Eastell,et al.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.

[53]  R. Eastell,et al.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.

[54]  David F. Schneider,et al.  Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism. , 2013, Surgery.

[55]  S. Zouwail,et al.  Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism. , 2013, Annals of the Royal College of Surgeons of England.

[56]  D. Borderie,et al.  Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. , 2013, The Journal of clinical endocrinology and metabolism.

[57]  X. Badia,et al.  Development of a new tool for assessing Health-Related Quality of Life in patients with primary hyperparathyroidism , 2013, Health and Quality of Life Outcomes.

[58]  S. Wiseman,et al.  Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior? , 2013, American journal of surgery.

[59]  A. Adams,et al.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. , 2013, The Journal of clinical endocrinology and metabolism.

[60]  P. Chanson,et al.  Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. , 2013, The Journal of clinical endocrinology and metabolism.

[61]  Herb Chen,et al.  What is the utility of distal forearm DXA in primary hyperparathyroidism? , 2012, The oncologist.

[62]  R. Lifton,et al.  Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism , 2012, Hormones and Cancer.

[63]  M. Pearle,et al.  Defining hypercalciuria in nephrolithiasis. , 2011, Kidney International.

[64]  P. Vestergaard,et al.  Nephrolithiasis and renal calcifications in primary hyperparathyroidism. , 2011, The Journal of clinical endocrinology and metabolism.

[65]  M. Cooper,et al.  Review: New perspectives in the management of primary hyperparathyroidism , 2010, Therapeutic advances in endocrinology and metabolism.

[66]  K. Foley,et al.  Urine Calcium: Laboratory Measurement and Clinical Utility , 2010 .

[67]  E. Hauge,et al.  Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case‐control study using HR‐pQCT , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  J. Pasieka,et al.  The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. , 2009, Surgery.

[69]  J. Miller,et al.  Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  C. Marcocci,et al.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. , 2009, The Journal of clinical endocrinology and metabolism.

[71]  R. Lazar,et al.  Neuropsychological features in primary hyperparathyroidism: a prospective study. , 2009, The Journal of clinical endocrinology and metabolism.

[72]  Martha A Zeiger,et al.  Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. , 2008, Surgery.

[73]  S. Challinor,et al.  Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism. , 2008, Surgery.

[74]  E. Siris,et al.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. , 2008, The Journal of clinical endocrinology and metabolism.

[75]  G. Curhan,et al.  24-h uric acid excretion and the risk of kidney stones. , 2008, Kidney international.

[76]  H. Teede,et al.  Fracture prevention strategies in patients presenting to Australian hospitals with minimal‐trauma fractures: a major treatment gap , 2007, Internal medicine journal.

[77]  B. Skogseid,et al.  Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. , 2007, The Journal of clinical endocrinology and metabolism.

[78]  M. Rubin,et al.  Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. , 2007, The Journal of clinical endocrinology and metabolism.

[79]  C. Marcocci,et al.  Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. , 2007, The Journal of clinical endocrinology and metabolism.

[80]  A. Gill,et al.  Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias , 2006, The American journal of surgical pathology.

[81]  Lindi H Vanderwalde,et al.  The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. , 2006, Archives of surgery.

[82]  J. Rastad,et al.  Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. , 2006, European journal of endocrinology.

[83]  Martin Coulombe,et al.  Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. , 2006, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[84]  G. Divine,et al.  Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. , 2004, The Journal of clinical endocrinology and metabolism.

[85]  Jeffrey E. Lee,et al.  Parathyroid carcinoma: A 22‐year experience , 2004, Head & neck.

[86]  R. Dickerson,et al.  Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[87]  P. Vestergaard,et al.  Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study , 2004, Journal of internal medicine.

[88]  J. Carpten,et al.  Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.

[89]  P. Vestergaard,et al.  Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism , 2003, BMJ : British Medical Journal.

[90]  S. Silverberg,et al.  Age as a criterion for surgery in primary hyperparathyroidism. , 2002, The American journal of medicine.

[91]  J. Rastad,et al.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. , 2002, The Journal of clinical endocrinology and metabolism.

[92]  P. Vestergaard,et al.  Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study , 2002, BMJ : British Medical Journal.

[93]  J. Ryan,et al.  Surgical treatment of hyperparathyroidism improves health-related quality of life. , 2002, Archives of surgery.

[94]  J. Rastad,et al.  Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. , 2000, The Journal of clinical endocrinology and metabolism.

[95]  W. O'Fallon,et al.  Primary Hyperparathyroidism and the Risk of Fracture: A Population‐Based Study , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[96]  I. Fleming,et al.  Two hundred eighty‐six cases of parathyroid carcinoma treated in the U.S. between 1985–1995 , 1999, Cancer.

[97]  J. Carney,et al.  Parathyroid Carcinoma: Clinical and Pathologic Features in 43 Patients , 1992, Medicine.

[98]  J. Knol,et al.  Malignancy and concomitant primary hyperparathyroidism , 1988, Journal of surgical oncology.

[99]  J. Rydberg,et al.  Hyperparathyroidism in the Elderly , 1983, Annals of surgery.

[100]  G. Mundy,et al.  PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATION , 1980, The Lancet.

[101]  J. V. van Heerden,et al.  Cancer of the parathyroid glands. , 1979, Archives of surgery.

[102]  B. Castleman,et al.  Parathyroid carcinoma. A study of 70 cases , 1973, Cancer.